d

M

DE FARIAS , Madson

Last name: DE FARIAS

First name: Madson

2023 (v1)

Publication

Metadata-only

Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients

Avenoso, Daniele Mehra, Varun Slonim, Liron Barnea

Background: Allogeneic haematopoietic stem cell transplant (HSCT) is a curative strategy for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). The prediction of transplant related mortality (TRM) using the HCT-CI score and an arbitrary upper limit of 55 years for administering myeloablative conditioning (MAC) are common...

Uploaded on: February 13, 2024